Value of C-Reactive Protein as a Risk Factor for Acute Coronary Syndrome: A Comparison with Apolipoprotein Concentrations and Lipid Profile

• Main Authors: Magdalena Krintus, Marek Kozinski, Anna Stefanska, Marcin Sawicki, Karolina Obonska, Tomasz Fabiszak, Jacek Kubica, Grazyna Sypniewska
• Format: Article
• Language: English
• Published: Hindawi Limited 2012-01-01
• Series: Mediators of Inflammation
• Online Access: http://dx.doi.org/10.1155/2012/419804
• ISSN: 0962-9351; 1466-1861

Objective. To investigate whether assessment of C-reactive protein (CRP) and apolipoproteins, besides the traditional lipid profile, enhances the assessment process for the risk of acute coronary syndrome (ACS). Methods. The study group consisted of 220 consecutive patients admitted to hospital within the first 6 hours from the onset of chest pain. Patients were diagnosed with unstable angina (), non-ST-elevation myocardial infarction (NSTEMI; ), or ST-elevation myocardial infarction (STEMI; ). ACS patients were compared with 116 healthy volunteers in a case-control study. The serum was assayed on admission for CRP, apolipoproteins ApoAI and ApoB100, and lipid parameters. Results. The highest concentrations of CRP were found in NSTEMI and STEMI, with a median value four-fold higher in ACS patients than in controls (). Only CRP significantly increased the probability of ACS development (adjusted odds ratio for a 1 mg/L increase 1.90; 95% confidence interval [CI] 1.34–2.89) and explained 90% of the variation for ACS development. Similarly, we demonstrated the highest diagnostic accuracy for CRP among all investigated markers (area under the curve 0.80; 95% CI 0.75–0.85). Conclusions. Our study indicates that CRP superiorly to apolipoproteins and lipid profile facilitates the risk stratification for ACS occurrence.